Fabricante de polvo de esteroides anabólicos de China
EnglishAfrikaansБългарскиNederlandsFrançaisDeutschItaliano日本語LatīnaNorskپارسیPolskiPortuguêsRomânăРусскийSlovenčinaSlovenščinaEspañolSvenskaTürkçeУкраїнська

Péptidos farmacéuticos

» Péptidos » Péptidos farmacéuticos

  • Presupuesto
  • Descripción del Producto
  • Uso del producto
  • COA
Nombre del producto Triptorelin Acetate
CAS NO. 140194-24-7
MF C64H82N18O13
megavatio 1311.45
EINECS NO. N / A
Pureza 99%
Apariencia White freeze dried powder
Almacenamiento Store at -20°C

Triptorelin is a gonadotropin-releasing hormone agonist used as the acetate or pamoate salts. By causing constant stimulation of the pituitary, it decreases pituitary secretion of gonadotropins luteinizing hormone and follicle stimulating hormone. Like other GnRH agonists, triptorelin may be used in the treatment of hormone-responsive cancers such as prostate cancer or breast cancer, precocious puberty, estrogen-dependent conditions, y en reproducción asistida. Triptorelin is marketed under the brand names Decapeptyl and Diphereline and Gonapeptyl.

Triptorelin,a decapeptide (pGlu-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH2), is a gonadotropin-releasing hormone agonist (GnRH agonist) used as the acetate or pamoate salts. By causing constant stimulation of the pituitary, it decreases pituitary secretion of gonadotropins luteinizing hormone (LH) y hormona folículo estimulante (FSH). Like other GnRH agonists, triptorelin may be used in the treatment of hormone-responsive cancers such as prostate cancer or breast cancer, precocious puberty, estrogen-dependent conditions (such as endometriosis or uterine fibroids), y en reproducción asistida. It is also used as therapy in cases of gender dysphoria.

Triptorelin is a GNRH agaonist shown to inhibit estradiol-induced cancer cell proliferationIn vivo.

1. Triptorelin can improve the pregnancy rate by 12% a 15% in ewes6 and downregulate ovarian GNRHR-I expression of female rats, especially in late-growing follicles.

2. Triptorelin immunity blocked EET and UWT, inhibited uterine growth and development and enhance the expression levels s of ESR1, LHR, and FSHR proteins.

3. Triptorelin may be used in the treatment of hormone-responsive cancers such as breast cancer or prostate cancer, precocious puberty, estrogen-dependent conditions, and assisted reproduction.

Impureza única (HPLC): 1.0%máximo
Composición de aminoácidos: ±10% del teórico
Contenido de péptidos (NORTE%): ≥80,0%
Contenido de agua(Karl Fischer): ≤6,0%
Triptorelin Acetate Acetate Content (HPIC): ≤15,0%
Triptorelin Acetate MS(ESI): Coherente
Triptorelin Acetate Mass Balance: 95.0~105,0%
Triptorelin Acetate Specific Rotation (20/D): -65.0~-75.0°(c=0,5 1%HAc)

Formulario de consulta ( Te responderemos lo antes posible. )

Nombre:
*
Correo electrónico:
*
Mensaje:

Verificación:
5 + 9 = ?

Quizás a ti también te guste

  • Nuestra ventaja

    Buen precio

    Alta calidad

    Entrega rápida

    Envío seguro

    Excelente servicio postventa

  • Almacén Local

    Almacén de la UE

    Almacén del Reino Unido

    Almacén de EE. UU.

    Almacén de Canadá

    Almacén de Australia

  • Método de pago

    PayPal

    bitcóin

    Transferencia bancaria

    gramo de dinero

    Western Union

  • Contáctenos

    Correo electrónico: jacob@steroid-peptide.com

    WhatsApp: +8615636286252

    Teléfono: 0086-15636286252

    Sitio web: www.steroid-peptide.com

    Bienvenido a su consulta

  • Servicio